Roswell Park Cancer Inst. — Buffalo, New York

Roswell Park Cancer Inst. is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Roswell Park Cancer Inst. has participated in 7 clinical trials.

Therapeutic areas: Non-Small Cell Lung Cancer, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia.

Sponsors: Genentech, Inc., Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Cancer Inst.?

Roswell Park Cancer Inst. has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Cancer Inst. conducted?

Roswell Park Cancer Inst. has 7 clinical trials on record. Their work covers Non-Small Cell Lung Cancer, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia.

Is Roswell Park Cancer Inst. accredited by Crixeo Health?

Roswell Park Cancer Inst. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Cancer Inst.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.